At MedSIR, through extensive internal processes, we work hard to identify and select the top international research groups and centers of excellence to carry out our clinical trials in the most efficient manner possible. These partners are of great importance to our success. We are indeed grateful to them for their efforts in helping us advance cancer research one step further.
Currently running trials across the European continent, such as the PHERGain, PARSIFAL, THELMA, BioPER and MERIBEL trials that explore the efficacy and safety of drugs such as pertuzumab, trastuzumab, T-DM1, eribulin, and palbocilcib, MedSIR also has plans to expand to other major markets in its goal to fully internationalize its clinical research projects.
Please use the project menu below to view the centers which have participated, or are currently participating, in one or more of our projects. If you need any further information regarding a specific study, please do not hesitate to contact us. We would be glad to help!